MedTrace Logo

Magnetic Seed Localisation of Breast Cancers

NCT02635737 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2021-01-15

Study results available
· View outcomes & findings →

Summary

This is a single site, single arm, unblinded safety and feasibility cohort study investigating the use of magnetic marker seeds to localise breast tumours.

Conditions

Interventions

DEVICE

Sentimark

Placement of a metallic clip with paramagnetic properties for tumour localisation

Sponsors & Collaborators

  • Endomagnetics Inc

    collaborator INDUSTRY

  • Manchester University NHS Foundation Trust

    lead OTHER_GOV

Principal Investigators

  • James R Harvey, MBBS PhD · University Hospital of South Manchester

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-06
Primary Completion
2017-05-03
Completion
2017-05-03

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02635737 on ClinicalTrials.gov